The center has signed a contract with Hyderabad-based vaccine maker Biological-E and booked 30 Cr doses of the vaccine.
Image for representation.
The center has signed agreements with Hyderabad-based vaccine maker Biological-E and booked doses of 30 crore. This will be the second vaccine made in India after Covaxin by Bharat Biotech.
These vaccine doses will be manufactured and stored by M / s Biological-E from August to December 2021. The Union Ministry of Health would make an advance payment of Rs. 1500 crore to the manufacturer.
Biological-E’s Covid-19 vaccine is currently in a Phase 3 clinical trial after showing promising results in Phase 1 and 2 clinical trials.
The vaccine developed by Biological-E is an RBD protein subunit vaccine and is expected to be available in the next few months.
The manufacturer’s proposal was examined after due diligence by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) and recommended for approval.
READ: India can compensate Pfizer, Moderna for its Covid vaccines. But what does it mean?
READ: Officials sitting on untapped potential to manufacture vaccines face manslaughter charges: Delhi HC
Click here for IndiaToday.in’s full coverage of the corona pandemic.
एक टिप्पणी भेजें